4,4,5,5-Tetramethyl-2-(3-((2,2,2-trifluoroethyl)sulfinyl)phenyl)-1,3,2-dioxaborolane, 97%, 250mg

2H-Pyrido[4,3-b][1,4]oxazin-3(4H)-one, 95.0%, 1g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4S,4'S,5R,5'R)-, 98%, 250mg

4-(3-Methoxyphenyl)-1h-pyrrole-3-carboxylic acid, 95%, 100mg

12-Bromododec-1-ene, 95.0%, 100mg

3-(Benzo[d]thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide, 98%, 50mg

(3-Bromo-5-trifluoromethyl-pyridin-2-yl)dimethylamine, 95.0%, 1g

GLIPIZIDE, 95%, 25mg

Cubeta de muestra UniPak®, 365 ml, 100 Unidad(es)

ethyl 4-isocyanatobenzoate, 95.0%, 5g

3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(trifluoromethyl)phenyl]amino]-3-cyclobutene-1,2-dione, 97%, 100mg

(2-Oxo-4-phenyl-pyrrolidin-1-yl)acetic acid, 95.0%, 250mg

4-Iodotoluene, 99.0%, 500g